[Mycobacterial bovis BCG cutaneous infections following mesotherapy: 2 cases].
BACKGROUND
Infectious complications following mesotherapy are usually due to ordinary bacteria or atypical mycobacteria. We report two new cases of mycobacterial bovis BCG infections following mesotherapy. To our knowledge only one case has already been reported.


METHODS
A 52 year-old woman developed vaccinal MERIEUX BCG cutaneous abscesses following mesotherapy. Identification was made by a novel class of repeated sequences: Mycobacterial interspersed repetitive units. Despite prolonged anti-tuberculous therapy, complete remission was not obtained and surgical excision was performed. The second case was a 49 year-old man who developed a mycobacterial bovis BCG cutaneous abscess (Connaught) after mesotherapy, the regression of which was obtained with anti-tuberculous therapy.


CONCLUSIONS
The severity of these two mycobacterial infections following mesotherapy illustrate the potential risks of mesotherapy. Identification is possible by molecular biology techniques (PCR and sequencing). The origin of this infection is unclear and therapeutic decision is difficult. Some authors recommend anti-tuberculous therapy but surgical excision may be necessary as in our cases.
Service de Dermatologie, Hôpital Haut-Lévêque, CHU de Bordeaux, France.
J
J
Marco-Bonnet
M
M
Beylot-Barry
J
J
Texier-Maugein
J P
JP
Barucq
P
P
Supply
M S
MS
Doutre
C
C
Beylot
D000038:Abscess / Q000209:etiology*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009163:Mycobacterium bovis; D014382:Tuberculosis, Cutaneous / Q000209:etiology*